Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil

Pediatric Dermatology

Volumn 28, Issue 6, 2011, Pages 689-694

  Waxweiler, Weston T ^a   Agans, Robert ^b   Morrell, Dean S ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THIOPURINE METHYLTRANSFERASE;

ABNORMAL LABORATORY RESULT; ADOLESCENT; AFRICAN AMERICAN; ARTICLE; ATOPIC DERMATITIS; CAUCASIAN; CELLULITIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG USE; DRUG WITHDRAWAL; EOSINOPHIL COUNT; FEMALE; FOLLICULITIS; HEMOGLOBIN BLOOD LEVEL; HISPANIC; HUMAN; INFECTION RATE; LEUKOCYTE COUNT; LIVER FUNCTION TEST; MALE; MORBIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; SKIN INFECTION; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; AZATHIOPRINE; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; METHYLTRANSFERASES; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 81255168050     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01488.x     Document Type: Article

References (17)

1. Gelbard CM, Hebert AA,. New and emerging trends in the treatment of atopic dermatitis. Patient Prefer Adherence 2008; 2: 387-392.
2. Schmitt J, Schakel K, Schmitt N, et al., Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol 2007; 87: 100-111. (Pubitemid 46521989)
3. Meggitt SJ, Gray JC, Reynolds NJ,. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 2006; 367: 839-846. (Pubitemid 43363371)
4. Murphy LA, Atherton DJ,. Azathioprine as a treatment for severe atopic eczema in children with a partial thiopurine methyl transferase (TPMT) deficiency. Pediatr Dermatol 2003; 20: 531-534. (Pubitemid 38021322)
5. Borchard KL, Orchard D,. Systemic therapy of paediatric atopic dermatitis: an update. Australas J Dermatol 2008; 49: 123-134; quiz 135-136. (Pubitemid 352000506)
6. Murphy LA, Atherton D,. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression. Br J Dermatol 2002; 147: 308-315.
7. Ballester I, Silvestre JF, Perez-Crespo M, et al., [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients]. Actas Dermosifiliogr 2009; 100: 883-887.
8. Berth-Jones J, Takwale A, Tan E, et al., Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002; 147: 324-330.
9. Hon KL, Ching GK, Leung TF, et al., Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults. J Dermatolog Treat 2009; 20: 141-145.
10. BuBmann C, Bieber T, Novak N,. Systemic therapeutic options for severe atopic dermatitis. J Dtsch Dermatol Ges 2009; 7: 205-219.
11. Leung DY, Bieber T,. Atopic dermatitis. Lancet 2003; 361: 151-160. (Pubitemid 36092023)
12. Murray ML, Cohen JB,. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Clin Exp Dermatol 2007; 32: 23-27. (Pubitemid 46006360)
13. Heller M, Shin HT, Orlow SJ, et al., Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. Br J Dermatol 2007; 157: 127-132. (Pubitemid 46934265)
14. Sidbury R, Hanifin JM,. Systemic therapy of atopic dermatitis. Clin Exp Dermatol 2000; 25: 559-566. (Pubitemid 32104621)
15. Bremmer MS, Bremmer SF, Baig-Lewis S, et al., Are biologics safe in the treatment of atopic dermatitis? A review with a focus on immediate hypersensitivity reactions. J Am Acad Dermatol 2009; 61: 666-676.
16. Akhavan A, Rudikoff D,. Atopic dermatitis: systemic immunosuppressive therapy. Semin Cutan Med Surg 2008; 27: 151-155. (Pubitemid 351938751)
17. Dhar S, Malakar R, Chattopadhyay S, et al., Correlation of the severity of atopic dermatitis with absolute eosinophil counts in peripheral blood and serum IgE levels. Indian J Dermatol Venereol Leprol 2005; 71: 246-249. (Pubitemid 41191360)